Mentari Therapeutics, Inc.'s next confirmed earnings release is scheduled for February 16, 2027.
| Earnings Date | 2/16/2027 |
As of the close on November 16, 2026, Mentari Therapeutics, Inc.'s stock has declined approximately 88.35% over the past 52 weeks. The 50-day moving average sits at 120.16, while the 200-day moving average is 117.41.
| 52-Week Price Change | -88.35% |
| 50-Day Moving Average | 120.16 |
| 200-Day Moving Average | 117.41 |
Mentari Therapeutics, Inc.'s most recent stock split took place on November 5, 2026 with a 10:1 split ratio.
| Last Split Date | 11/5/2026 |
| Split Ratio | 10:1 |